XML 27 R76.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation - Additional Information (Detail) (USD $)
In Millions, except Share data, unless otherwise specified
12 Months Ended 1 Months Ended 1 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended
May 31, 2013
May 31, 2012
May 31, 2011
May 31, 2013
Stock Appreciation Rights (SARs)
May 31, 2013
Share-based performance-earned restricted stock ("PERS")
May 31, 2012
Share-based performance-earned restricted stock ("PERS")
May 31, 2011
Share-based performance-earned restricted stock ("PERS")
May 31, 2013
Non Vested Restricted Stock
May 31, 2012
Non Vested Restricted Stock
May 31, 2011
Non Vested Restricted Stock
Jul. 31, 2012
Performance Contingent Restricted Stock
Jun. 30, 2012
Performance Contingent Restricted Stock
Jul. 31, 2011
Performance Contingent Restricted Stock
Oct. 31, 2010
Performance Contingent Restricted Stock
May 31, 2013
Performance Contingent Restricted Stock
Oct. 31, 2010
Performance Contingent Restricted Stock
First Performance Segment
Oct. 31, 2010
Performance Contingent Restricted Stock
Second Performance Segment
May 31, 2013
Restricted Stock Unit
Jun. 30, 2012
Restricted Stock
May 31, 2013
Restricted Stock
May 31, 2013
Omnibus Incentive Plan
May 31, 2013
Omnibus Incentive Plan
Full Value Stock Award
Oct. 10, 2003
Restricted Stock Plans, 2003 Plan
May 31, 2013
Restricted Stock Plans, 2003 Plan
May 31, 2012
Restricted Stock Plans, 2003 Plan
May 31, 2011
Restricted Stock Plans, 2003 Plan
May 31, 2013
Employee Incentive Plan Twenty Zero Seven
May 31, 2012
Employee Incentive Plan Twenty Zero Seven
May 31, 2011
Employee Incentive Plan Twenty Zero Seven
May 31, 2013
Employee Incentive Plan Twenty Zero Seven
Scenario 1
May 31, 2013
Nineteen Ninety Seven Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                                              
Incentive plan approval date                                         Oct. 08, 2004   Oct. 10, 2003                
Stock appreciation rights expected term 7 years 6 months 7 years 6 months 7 years 6 months 10 years                                                      
Share based compensation arrangement vesting period       4 years 3 years                                   3 years                
Stock options outstanding 302,238     3,200,250                                                      
Aggregate intrinsic value of options outstanding $ 44.1                                                            
Weighted-average remaining contractual life of options outstanding 5 years 10 months 24 days                                                            
Aggregate intrinsic value of options exercisable 29.1                                                            
Weighted-average remaining contractual life of options exercisable 4 years 6 months                                                            
Unamortized stock-based compensation expense       4.4 13.2     24.6             4.1     1.1           1.2     4.9       0.1
Unamortized stock-based compensation expense expected recognition period       3 years 3 months       3 years 2 months 12 days                                              
Shares expected to vest       1,400,000                                                      
Shares expected to vest, weighted-average exercise price       $ 22.73                                                      
Shares expected to vest, weighted-average remaining contractual term       7 years 9 months 18 days                                                      
Shares of common stock available for grant                                         12,000,000 6,000,000                  
Shares granted to Directors         $ 26.22 $ 21.49 $ 19.31 $ 26.16     $ 25.87 $ 25.76 $ 22.16 $ 20.73                   $ 26.63 $ 20.60 $ 20.73 $ 25.87        
Shares granted         495,000     678,000     50,000 10,000 115,000 680,000                   35,000     89,000        
Performance goals attainment period for PCRS awards                               3 years 5 years                            
Shares expected to vest 2.5                           394,521                                
Shares outstanding         1,454,000 1,070,000                 855,000                       815,000 778,000      
Shares earned, but not vested               3,236,000 2,758,000           392,500                 113,000 115,000            
Shares of common stock available for grant                                             500,000 192,750     234,707     1,000,000  
Weighted-average grant-date fair value         $ 22.31 $ 20.18                                         $ 25.87 $ 22.16 $ 17.88    
Remaining weighted-average contractual term 3 years 2 months 12 days             3 years 2 months 12 days                                              
Weighted-average grant-date fair value               $ 26.16 $ 21.62 $ 19.97                                          
Total fair value of shares vested 3.3 7.0 10.8                                                        
Shares expected to vest, weighted-average grant-date fair value $ 20.94                                                            
Shares of restricted stock vested         92,000     171,000                     56,291 45,194       37,000     43,000        
Total intrinsic value of restricted shares converted $ 1.3 $ 3.1 $ 0.6